You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (110)

Journals (0)

1-10 of 110 results for cyclin-dependent kinases 4 and 6

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment

Retricted access

Research article

First published 2019-1

Role of cyclin-dependent kinase 4/6 inhibitors in the current and future eras of cancer treatment

S Parylo, A Vennepureddy, V Dhar [...]

Journal of Oncology Pharmacy Practice

Select article: A case of biopsy proven acute tubular injury from cyclin dependent kinase 4/6 inhibitor

Retricted access

Case report

First published 2024-6

A case of biopsy proven acute tubular injury from cyclin dependent kinase 4/6 inhibitor

Meghan Gwinn, Kammi Henriksen, Marco Bonilla

Journal of Onco-Nephrology

Select article: Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors

Retricted access

Research article

First published 2024-12

Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors

Tanju Kapagan, Nilufer Bulut, Gokmen Umut Erdem

Journal of Oncology Pharmacy Practice

Select article: Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database

Open access

Research article

First published 2022-12

Haematopoietic cytopenia associated with cyclin-dependent kinase 4/6 inhibitors: A real-world study of data from the food and drug administration adverse event reporting system database

Xiayang Ren, Cilin Yan, Le Tian [...]

International Journal of Immunopathology and Pharmacology

Select article: Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

Retricted access

Review article

First published 2024-4

Cyclin-dependent kinase 4/6 inhibitors in the treatment of advanced or metastatic breast cancer

John P Micha, Mark A Rettenmaier, Randy D Bohart [...]

Journal of Oncology Pharmacy Practice

Select article: Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer

Retricted access

Review article

First published 2019-2

Review of Cyclin-Dependent Kinase 4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Advanced Breast Cancer

Keith A. Hecht, Christopher Selby

Annals of Pharmacotherapy

Select article: Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer

Open access

Review article

First published 2018

Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer

Marc Thill, Marcus Schmidt

Therapeutic Advances in Medical Oncology

Select article: Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib

Retricted access

Case report

First published 2023-6

Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib

Christina Watts, Karin Nadori

Journal of Oncology Pharmacy Practice

Select article: Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Retricted access

Review article

First published 2023-12

Updated Review Article: Cyclin-Dependent Kinase 4/6 Inhibitor Impact,FDA Approval,and Resistance Pathways

Rodney J. Hunter, Jooyoung Park, Kristen J. Asprer [...]

Journal of Pharmacy Technology

Select article: Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer

Retricted access

Case report

First published 2023

Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer

Alper Türkel, Cengiz Karaçin, İrem Öner [...]

Journal of Oncology Pharmacy Practice

1
2
3
•••
11
10 / page

Article type

Publication date

Subjects

Access